Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine

N Engl J Med. 2005 Oct 13;353(15):1630-1; author reply 1630-1. doi: 10.1056/NEJMc052065.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • DNA, Viral / blood
  • Drug Therapy, Combination
  • Hepatitis B e Antigens / blood
  • Hepatitis B virus / drug effects*
  • Hepatitis B virus / genetics
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Lamivudine / therapeutic use
  • Polyethylene Glycols / therapeutic use*
  • Recombinant Proteins

Substances

  • Antiviral Agents
  • DNA, Viral
  • Hepatitis B e Antigens
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Lamivudine
  • Polyethylene Glycols
  • peginterferon alfa-2a